Institutional holders of Liquidia Corporation rise to 366, total investment hits $6B
Summary
Institutional ownership of Liquidia has seen a significant rise, with 366 institutional holders now reported, including 235 funds that have increased their positions, bringing total investment to $5.8 billion. This uptick in ownership comes as the company has recently reached a global settlement with United Therapeutics, allowing for the ongoing commercialization of its drug YUTREPIA for pulmonary arterial hypertension, which is a central focus for the firm's growth alongside its other pipeline candidates.
Tokens
$LQDA
Analysis
LQDA: Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing inhaled therapies for pulmonary and vascular diseases. Its lead product, YUTREPIA, is an inhaled dry-powder formulation of treprostinil approved for treating pulmonary arterial hypertension. The reported rise in institutional holders for LQDA reflects sustained investor attention to the company's commercial progress and pipeline. Product Focus: The company is prioritizing growth of YUTREPIA in its approved indication while advancing additional pipeline candidates. Legal Resolution: Liquidia reached a global settlement resolving multiple lawsuits with United Therapeutics, enabling continued commercialization of YUTREPIA for pulmonary arterial hypertension.
Categories
on_chain_whalecryptodats
Related sources
- https://seekingalpha.com/news/4652729-liquidia-rockets-42-as-3807m-deal-ends-united-therapeutics-legal-battle
- https://www.wallstreetzen.com/stocks/us/nasdaq/lqda/ownership
- https://www.stocktitan.net/news/LQDA/
- https://www.insiderset.com/stocks/LQDA
- https://businessquant.com/stocks/lqda/insiders/
- https://www.themarketsdaily.com/2026/10/14/liquidia-nasdaqlqda-shares-gap-up-whats-next.html
- https://businessquant.com/stocks/lqda/institutional-ownership/
- https://www.reuters.com/legal/litigation/liquidia-surges-after-381-million-settlement-with-united-therapeutics-lung-2026-10-14/
- https://www.macroaxis.com/ownership/LQDA/Liquidia-Technologies
- https://www.tipranks.com/news/liquidia-stock-lqda-pops-as-380-7m-deal-ends-legal-battle-with-united-therapeutics